Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.45 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7945985 | 0.86 | KMT2A (0.61) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL11317004 | 0.86 | ALDH1A1 (0.59) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL11317002 | 0.86 | ALDH1A1 (0.59) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL11838507 | 0.82 | HPGD (0.62) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL29493736 | 0.79 | KMT2A (0.94) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| Fluorene SCHEMBL30173241 | 0.79 | MAOA (0.65) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL3401938 | 0.79 | KMT2A (0.94) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL14520877 | 0.77 | ALDH1A1 (0.66) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| Fluorene SCHEMBL30898827 | 0.76 | MAOA (0.62) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL29941712 | 0.76 | KMT2A (1.00) | MEN1KMT2AALDH1A1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462542-A | Cyanuric chloride oxime ester and synthesis method thereof | 九江善水科技股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| US-7807841-B2 | Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors | IRM LLC (BM) | 2010-10-05 | — | — | US | disclosed |
| US-20090124597-A1 | SPIRO-CONTAINING COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS | IRM LLC (BM) | 2009-05-14 | — | — | US | disclosed |
| EP-1137703-B1 | STABILIZED THERMOPLASTIC COMPOSITIONS | CROMPTON CORP (US) | 2005-12-28 | — | — | EP | disclosed |
| EP-1137703-A1 | STABILIZED THERMOPLASTIC COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2001-10-04 | — | — | EP | disclosed |
| US-6214915-B1 | AROMATIC KETONE STABILIZER | GENERAL ELECTRIC COMPANY | 2001-04-10 | — | — | US | disclosed |
| WO-2000034373-A1 | STABILIZED THERMOPLASTIC COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124597-A1 | SPIRO-CONTAINING COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS | NR3C2, NR5A1, ESRRA | MEN1 1744/4885KMT2A 3845/4885ALDH1A1 1202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.